Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00377286 · ClinicalTrials.gov registry record · NA

Effect of Glucosamine on Joint Structure and Quality of Life (JOG)

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
201
Enrollment target

NCT00377286 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 201 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00377286, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target

Study Summary

The goal of this study is 1) to develop a biomarker of of cartilage synthesis by determining if there is a relationship between changes in the status of knee cartilage and the amount of a biomarker called CTX-II in urine. 2) We will also characterize people who have experienced cartilage loss and/or reduced functional ability using performance tests and a questionnaire. 3) The administration of glucosamine in a beverage for six months will be used to promote the alteration in cartilage status and improve function in people with mild to moderate joint pain. A secondary goal will be to assess the effect of glucosamine on the skin in a small subset of women.

Interventions

  • DIETARY_SUPPLEMENT Glucosamine (a dietary supplement)
  • OTHER 16 oz lite lemonade

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2006-09
Est. Completion 2008-05
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00377286

The ClinicalTrials.gov registry entry for NCT00377286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Glucosamine (a dietary supplement) is the first listed.

NCT00377286 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00377286 about?

NCT00377286 is a clinical study titled "Effect of Glucosamine on Joint Structure and Quality of Life (JOG)". The goal of this study is 1) to develop a biomarker of of cartilage synthesis by determining if there is a relationship between changes in the status of knee cartilage and the amount of a biomarker called CTX-II in urine. 2) We will also characterize people who have experienced cartilage loss and/or...

What is the current status of trial NCT00377286?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2006-09. Estimated completion is 2008-05.

What interventions are being tested in trial NCT00377286?

The interventions under investigation include: Glucosamine (a dietary supplement) (DIETARY_SUPPLEMENT), 16 oz lite lemonade (OTHER).

Who is sponsoring clinical trial NCT00377286?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.